Table 2.
Characteristic | Observation (n = 179) |
WBRT (n = 180) |
Total (N = 359) |
|||
---|---|---|---|---|---|---|
No. of Patients | % | No. of Patients | % | No. of Patients | % | |
Age, years | ||||||
Median | 61 | 60 | 60 | |||
Range | 37-80 | 26-81 | 26-81 | |||
Sex | ||||||
Male | 122 | 68 | 113 | 63 | 235 | 65 |
Female | 57 | 32 | 67 | 37 | 124 | 35 |
WHO performance status | ||||||
0 | 82 | 46 | 75 | 42 | 157 | 44 |
1 | 78 | 44 | 84 | 47 | 162 | 45 |
2 | 19 | 11 | 21 | 12 | 40 | 11 |
Neurologic status | ||||||
No deficit | 97 | 54 | 97 | 54 | 194 | 54 |
Some deficit, useful work | 52 | 29 | 54 | 30 | 106 | 30 |
Moderate impairment | 29 | 16 | 29 | 16 | 58 | 16 |
Major impairment | 1 | 1 | 0 | 0 | 1 | 0 |
Localization of primary tumor | ||||||
Lung (NSCLC) | 93 | 52 | 97 | 54 | 190 | 53 |
Breast | 20 | 11 | 22 | 12 | 42 | 12 |
Kidney | 13 | 7 | 16 | 9 | 29 | 8 |
Colorectal | 16 | 9 | 14 | 8 | 30 | 8 |
Melanoma | 8 | 5 | 10 | 6 | 18 | 5 |
Other | 15 | 8 | 12 | 7 | 27 | 8 |
CUP | 14 | 8 | 9 | 5 | 23 | 6 |
Macroscopic tumor outside the brain | ||||||
Absent | 89 | 50 | 79 | 44 | 168 | 47 |
Present | 82 | 46 | 91 | 51 | 173 | 48 |
Unknown | 8 | 4 | 10 | 6 | 18 | 5 |
Abbreviations: WBRT, whole-brain radiotherapy; NSCLC, non–small-cell lung cancer; CUP, cancer of unknown primary tumor.